Webinar: "What I've Learned in 20 Years of Patient Recruitment"

As medications become more targeted and sophisticated, the growing complexity of clinical trial protocols is making it more difficult than ever to find the perfect patients for your trials. That’s why a thoughtful and strategic patient recruitment strategy is key.   Read more

How We Delivered 300% of Our Clinical Trial Recruitment Goal [Case Study]

While approximately 15 to 20 percent of people 65+ have Mild Cognitive Impairment (MCI), it can be difficult to identify, and difficult to determine if it is related to Alzheimer’s disease. MCI does not always lead to dementia, but people with MCI are four times more likely to develop Alzheimer’s disease and other forms of dementia than those without it — so it’s important to treat this condition ... Read more

Uncontrolled Movements In Parkinson's: Why They Happen & What Can Help

Parkinson's disease is a movement disorder that can involve several different kinds of uncontrolled movements. Some are caused by the disease, such as tremor and gait freezing, while dyskinesia – uncontrolled jerking or twisting movement – is caused by long-term levodopa use. Read more

Eczema Research Roundup: August 2019

Today, 70% of the 18 million adults in the U.S. experience moderate-to-severe symptoms. Nearly half of people with eczema report that they "often" or "always" feel frustrated by their disease. One-third report that they spend up to three hours per day treating their disease.  Read more

10 Clinical Trial Recruitment Strategies That Work

The best clinical trial recruitment strategies start by considering the patient perspective. From there, it helps to get creative. A reliable clinical trial patient recruitment plan incorporates a range of outreach methods designed to reach patients quickly and efficiently while providing them with the information they need to take the next step.  Read more

Patient Centricity in Clinical Trials: Progress — and Miles to Go

A few years ago, we wrote a blog series for ACRP in which we focused on patient centricity in clinical trial design, recruitment, and execution. Over the next few months, we’ll be taking a second look at those blog posts, sharing updated versions on our own blog. Here’s an update to the first in that series.  Read more

What's Next for Alzheimer's Research?

An estimated 5.8 million people in the United States have been diagnosed with Alzheimer's disease. As the millions of patients and caregivers around the country know too well, there is not a treatment option that slows or stops disease progression. Read more

Crohn's Disease Research Round Up: Summer 2019

Crohn's disease is an Inflammatory Bowel Disease (IBD) that causes chronic inflammation in the digestive tract, leading to uncomfortable abdominal pain, severe diarrhea, cramping, and other symptoms. Read more

The Science of Clinical Trial Selection: Why Trial Type Matters to Patients

Living with a chronic illness or other condition can take up a significant piece of a patient's time. Though clinical trials can be beneficial to patients, recruitment efforts have to compete with many other products and services that can offer a patient support.  Read more

The Quickest Way to Meet Your Clinical Trial Quotas? Precision Recruitment

With patients waiting for new and better treatments and companies waiting for results, delays in clinical trials are far from ideal. And yet, here at Antidote, we receive calls and emails every day from researchers who are missing their trial’s deadlines because they’re having trouble finding patients to take part.  Read more